Independent Advisor Alliance Astrazeneca PLC Transaction History

Independent Advisor Alliance

$7.25 Billion
Q4 2024

A detailed history of Independent Advisor Alliance transactions in Astrazeneca PLC stock. As of the latest transaction made, Independent Advisor Alliance holds 3,847 shares of AZN stock, worth $277,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,847

Previous 3,405 12.98%

Holding current value

$277,330

Previous $265,000 4.91%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$63.2 - $79.58 $27,934 - $35,174	442 Added 12.98%	3,847 $252,000
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $1,533 - $1,752	-20 Reduced 0.58%	3,405 $265,000
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $14,096 - $17,055	-211 Reduced 5.8%	3,425 $267,000
Q1 2024 May 08, 2024	SELL	$61.03 - $69.57 $2,258 - $2,574	-37 Reduced 1.01%	3,636 $246,000
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $15,163 - $16,973	-245 Reduced 6.25%	3,673 $247,000
Q3 2023 Oct 24, 2023	SELL	$64.85 - $71.7 $47,664 - $52,699	-735 Reduced 15.8%	3,918 $265,000
Q2 2023 Jul 28, 2023	BUY	$69.91 - $75.81 $33,207 - $36,009	475 Added 11.37%	4,653 $333,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $263,840 - $299,144	4,178 New	4,178 $289,000
Q3 2022 Nov 04, 2022	SELL	$53.02 - $135.75 $4,930 - $12,624	-93 Reduced 1.65%	5,546 $304,000
Q2 2022 Aug 04, 2022	SELL	$59.26 - $71.14 $95,704 - $114,891	-1,615 Reduced 22.26%	5,639 $373,000
Q1 2022 May 06, 2022	BUY	$55.72 - $67.12 $31,036 - $37,385	557 Added 8.32%	7,254 $481,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $8,048 - $9,510	-149 Reduced 2.18%	6,697 $390,000
Q3 2021 Nov 01, 2021	BUY	$55.56 - $60.79 $75,506 - $82,613	1,359 Added 24.77%	6,846 $411,000
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $22,805 - $28,344	471 Added 9.39%	5,487 $329,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $329,931 - $380,862	-6,996 Reduced 58.24%	5,016 $249,000
Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $1.21 Million - $1.44 Million	-24,875 Reduced 67.44%	12,012 $601,000
Q3 2020 Nov 04, 2020	BUY	$53.07 - $61.1 $1.37 Million - $1.58 Million	25,891 Added 235.46%	36,887 $2.02 Million
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $185,243 - $237,722	4,298 Added 64.17%	10,996 $582,000
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $253,117 - $343,808	6,698 New	6,698 $299,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $211,723 - $241,934	-6,091 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$34.55 - $37.05 $210,444 - $225,671	6,091 New	6,091 $206,000
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $203,161 - $225,714	-6,162 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $197,738 - $214,314	6,162	6,162 $219,000

Others Institutions Holding AZN

# of Institutions

1,393

Shares Held

476M

Call Options Held

Put Options Held

4.4M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account

Independent Advisor Alliance Astrazeneca PLC Transaction History